Client Result
Orrick Advises Aledade on $123 Million Series E
June.06.2022

Returning investor OMERS Growth Equity led the round, which also included Fidelity Management & Research Company and other current investors.
June.06.2022
Returning investor OMERS Growth Equity led the round, which also included Fidelity Management & Research Company and other current investors.
June.06.2022
June.03.2022
June.01.2022
June.01.2022
June.01.2022
Congratulations to our client Assembled on its $51 million Series B financing round, led by New Enterprise Associates.
May.31.2022
May.24.2022
May.24.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.
May.24.2022
May.24.2022
May.23.2022
Orrick advised DIF Core Infrastructure Fund I on the sale of its majority stake in ADTIM SAS to HICL Infrastructure PLC.